Sarcomas Across the Age Spectrum

Seminars in Radiation Oncology

Volumn 20, Issue 1, 2010, Pages 45-51

  Wolden, Suzanne L ^a   Alektiar, Kaled M ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DACTINOMYCIN; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; VINCRISTINE;

ADJUVANT CHEMOTHERAPY; ADULT DISEASE; CANCER CLASSIFICATION; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CHILDHOOD CANCER; CLINICAL FEATURE; EWING SARCOMA; HUMAN; LIPOSARCOMA; MULTIMODALITY CANCER THERAPY; ONSET AGE; PRIORITY JOURNAL; PROTON THERAPY; RADIATION DOSE; REVIEW; RHABDOMYOSARCOMA; SARCOMA; SYNOVIAL SARCOMA;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; LIPOSARCOMA; MALE; MIDDLE AGED; RHABDOMYOSARCOMA; SARCOMA; SARCOMA, EWING'S; SARCOMA, SYNOVIAL; YOUNG ADULT;

EID: 70549114064     PISSN: 10534296     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semradonc.2009.09.003     Document Type: Review

References (41)

1. Gurney J., Young Jr. J., Roffers S., et al. Cancer incidence and survival among children and adolescents: United States SEER Program 1975-1995 (1999), National Cancer Institute, SEER Program, Bethesda, MD NIH Pub. No. 99-4649
2. Turc-Carel C., Lizard-Nacol S., Justrabo E., et al. Consistent chromosomal translocation in alveolar rhabdomyosarcoma. Cancer Genet Cytogenet 19 (1986) 361-362
3. Crist W.M., Anderson J.R., Meza J.L., et al. Intergroup rhabdomyosarcoma study-IV: Results for patients with nonmetastatic disease. J Clin Oncol 19 (2001) 3091-3102
4. Lawrence Jr. W., Hays D.M., Heyn R., et al. Lymphatic metastases with childhood rhabdomyosarcoma. A report from the Intergroup Rhabdomyosarcoma Study. Cancer 60 (1987) 910-915
5. Donaldson S.S., Meza J., Breneman J.C., et al. Results from the IRS-IV randomized trial of hyperfractionated radiotherapy in children with rhabdomyosarcoma-a report from the IRSG. Int J Radiat Oncol Biol Phys 51 (2001) 718-728
6. Wolden S.L., Anderson J.R., Crist W.M., et al. Indications for radiotherapy and chemotherapy after complete resection in rhabdomyosarcoma: A report from the Intergroup Rhabdomyosarcoma Studies I to III. J Clin Oncol 17 (1999) 3468-3475
7. Bolling T., Schuck A., Paulussen M., et al. Whole lung irradiation in patients with exclusively pulmonary metastases of Ewing tumors. Toxicity analysis and treatment results of the EICESS-92 trial. Strahlenther Onkol 184 (2008) 193-197
8. Donaldson S.S., and Anderson J.R. Rhabdomyosarcoma: Many similarities, a few philosophical differences. J Clin Oncol 23 (2005) 2586-2587
9. Klem M.L., Grewal R.K., Wexler L.H., et al. PET for staging in rhabdomyosarcoma: An evaluation of PET as an adjunct to current staging tools. J Pediatr Hematol Oncol 29 (2007) 9-14
10. Wolden S.L., Wexler L.H., Kraus D.H., et al. Intensity-modulated radiotherapy for head-and-neck rhabdomyosarcoma. Int J Radiat Oncol Biol Phys 61 (2005) 1432-1438
11. Yock T.I., Krailo M., Fryer C.J., et al. Local control in pelvic Ewing sarcoma: Analysis from INT-0091-A report from the Children's Oncology Group. J Clin Oncol 24 (2006) 3838-3843
12. Sultan I., Qaddoumi I., Yaser S., et al. Comparing adult and pediatric rhabdomyosarcoma in the surveillance, epidemiology and end results program, 1973 to 2005: An analysis of 2,600 patients. J Clin Oncol 27 (2009) 3391-3397
13. Kushner B.H., Hajdu S.I., Gulati S.C., et al. Extracranial primitive neuroectodermal tumors. The Memorial Sloan-Kettering Cancer Center experience. Cancer 67 (1991) 1825-1829
14. Parkin D.M., Stiller C.A., Nectoux J., et al. International variations in the incidence of childhood bone tumours. Int J Cancer 53 (1993) 371-376
15. Sreekantaiah C., Ladanyi M., Rodriguez E., et al. Chromosomal aberrations in soft tissue tumors. Relevance to diagnosis, classification, and molecular mechanisms. Am J Pathol 144 (1994) 1121-1134
16. Grier H.E., Krailo M.D., Tarbell N.J., et al. Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone. N Engl J Med 348 (2003) 694-701
17. Navid F., Santana V.M., Billups C.A., et al. Concomitant administration of vincristine, doxorubicin, cyclophosphamide, ifosfamide, and etoposide for high-risk sarcomas: The St. Jude Children's Research Hospital experience. Cancer 106 (2006) 1846-1856
18. Schuck A., Ahrens S., Paulussen M., et al. Local therapy in localized Ewing tumors: Results of 1058 patients treated in the CESS 81, CESS 86, and EICESS 92 trials. Int J Radiat Oncol Biol Phys 55 (2003) 168-177
19. Krasin M.J., Rodriguez-Galindo C., Billups C.A., et al. Definitive irradiation in multidisciplinary management of localized Ewing sarcoma family of tumors in pediatric patients: Outcome and prognostic factors. Int J Radiat Oncol Biol Phys 60 (2004) 830-838
20. La T.H., Meyers P.A., Wexler L.H., et al. Radiation therapy for Ewing's sarcoma: Results from Memorial Sloan-Kettering in the modern era. Int J Radiat Oncol Biol Phys 64 (2006) 544-550
21. Henderson T.O., Whitton J., Stovall M., et al. Secondary sarcomas in childhood cancer survivors: A report from the Childhood Cancer Survivor Study. J Natl Cancer Inst 9 (2007) 300-308
22. Kuttesch Jr. J.F., Wexler L.H., Marcus R.B., et al. Second malignancies after Ewing's sarcoma: Radiation dose-dependency of secondary sarcomas. J Clin Oncol 14 (1996) 2818-2825
23. Siegel R.D., Ryan L.M., Antman K.H., et al. Adults with Ewing's sarcoma. An analysis of 16 patients at the Dana-Farber Cancer Institute. Am J Clin Oncol 11 (1988) 614-617
24. Trassard M., Le Doussal V., Hacene K., et al. Prognostic factors in localized primary synovial sarcoma: A multicenter study of 128 adult patients. J Clin Oncol 19 (2001) 525-534
25. Lewis J.J., Antonescu C.R., Leung D.H., et al. Synovial sarcoma: A multivariate analysis of prognostic factors in 112 patients with primary localized tumors of the extremity. J Clin Oncol 18 (2000) 2087-2094
26. Ladanyi M., Antonescu C.R., Leung D.H., et al. Impact of SYT-SSX fusion type on the clinical behavior of synovial sarcoma: A multi-institutional retrospective study of 243 patients. Cancer Res 62 (2002) 135-140
27. Canter R.J., Qin L.X., Maki R.G., et al. A synovial sarcoma-specific preoperative nomogram supports a survival benefit to ifosfamide-based chemotherapy and improves risk stratification for patients. Clin Cancer Res 14 (2008) 8191-8197
28. Italiano A., Penel N., Robin Y.M., et al. Neoadjuvant chemotherapy does not improve outcome in resected primary synovial sarcoma: A study of the French Sarcoma Group. Ann Oncol 20 (2009) 425-430
29. Palmerini E., Staals E.L., Alberghini M., et al. Synovial sarcoma: Retrospective analysis of 250 patients treated at a single institution. Cancer 115 (2009) 2988-2998
30. Guadagnolo B.A., Zagars G.K., Ballo M.T., et al. Long-term outcomes for synovial sarcoma treated with conservation surgery and radiotherapy. Int J Radiat Oncol Biol Phys 69 (2007) 1173-1180
31. Eilber F.C., Brennan M.F., Eilber F.R., et al. Chemotherapy is associated with improved survival in adult patients with primary extremity synovial sarcoma. Ann Surg 246 (2007) 105-113
32. Sultan I., Rodriguez-Galindo C., Saab R., et al. Comparing children and adults with synovial sarcoma in the SEER program 1983 to 2005: An analysis of 1268 patients. Cancer 115 (2009) 3537-3547
33. Dalal K.M., Antonescu C.R., Singer S., et al. Diagnosis and management of lipomatous tumors. J Surg Oncol 97 (2008) 298-313
34. Schwab J.H., Boland P., Guo T., et al. Skeletal metastases in myxoid liposarcoma: An unusual pattern of distant spread. Ann Surg Oncol 14 (2007) 1507-1514
35. Dalal K.M., Kattan M.W., Antonescu C.R., et al. Subtype specific prognostic nomogram for patients with primary liposarcoma of the retroperitoneum, extremity, or trunk. Ann Surg 244 (2006) 381-391
36. Singer S., Socci N.D., Ambrosini G., et al. Gene expression profiling of liposarcoma identifies distinct biological types/subtypes and potential therapeutic targets in well-differentiated and dedifferentiated liposarcoma. Cancer Res 67 (2007) 6626-6636
37. Kooby D.A., Antonescu C.R., Brennan M.F., et al. Atypical lipomatous tumor/well-differentiated liposarcoma of the extremity and trunk wall: Importance of histological subtype with treatment recommendations. Ann Surg Oncol 11 (2004) 78-84
38. th Annual Meeting, Boston, MA. Int J Radiat Oncol Biol Phys 72 (2008) S107
39. Zagars G.K., Goswitz M.S., Pollack A., et al. Liposarcoma: outcome and prognostic factors following conservation surgery and radiation therapy. Int J Radiat Oncol Biol Phys 36 (1996) 311-319
40. Chung P.W., Deheshi B.M., Ferguson P.C., et al. Radiosensitivity translates into excellent local control in extremity myxoid liposarcoma: A comparison with other soft tissue sarcomas. Cancer 115 (2009) 3254-3261
41. Eilber F.C., Eilber F.R., Eckardt J., et al. The impact of chemotherapy on the survival of patients with high-grade primary extremity liposarcoma. Ann Surg 240 (2004) 686-695 discussion 695-687